News | August 14, 2024
Marksans Pharma Q1 FY25 revenue up 18%
Gross profit was Rs. 328.8 crore, up by 27.8% YoY with a gross margin expansion of 418 bps to 55.7%
Gross profit was Rs. 328.8 crore, up by 27.8% YoY with a gross margin expansion of 418 bps to 55.7%
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
He is also inducted as a member of the management council and senior management personnel of the company
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
The Business Undertaking of Watson is engaged in the business of developing, manufacturing, marketing and sale of API.
40,000 visitors and representatives of more than 80 countries set to visit the show
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Survey findings released in advance of World Lupus Day on May 10
Subscribe To Our Newsletter & Stay Updated
